1.98 USD
↘ 0.12 (5.54%)LIVE (AS OF 03:52 PM EDT)
BioNexus Gene Lab Corp Common stock
BGLCNASDAQ • USD
Market: OPEN
BioNexus Gene Lab Corp Common stock (BGLC) is currently trading at $1.98. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest BGLC is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 24, 2026.
Open?$2.11
High?$2.19
Low?$1.98
Prev. Close?$2.10
Volume?7.4K
Avg. Volume?200.4K
VWAP?$2.08
Rel. Volume?0.04x
Bid / Ask
Bid?$1.72 × 100
Ask?$2.41 × 100
Spread?$0.69
Midpoint?$2.07
Valuation & Ratios
Market Cap?5.1M
Shares Out?2.4M
Float?1.7M
Float %?71.0%
P/E Ratio?N/A
P/B Ratio?0.63
EPS?-$1.20
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
Employees
1
Market Cap
5.1M
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2020-03-11
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,
KUALA LUMPUR, N8 59200
Phone: 1-307-241-6898
KUALA LUMPUR, N8 59200
Phone: 1-307-241-6898
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?90
Momentum?14
Short Sent.?60
Piotroski F-Score?1/9Weak
Altman Z-Score?3.87Safe
Confidence?46%Low
Short InterestLow
Short % of Float?1.33%Low
Short Interest?22.3K
Days to Cover?1.0
Free Float1.7M
Avg Daily Volume59.5K
Settlement Date2026-05-29
Financial Health
Current Ratio?6.52Strong
Quick Ratio?5.69Strong
Cash Ratio?1.68Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.63CHEAP▾
Peers100
S&P97
P/S?0.96CHEAP▾
Peers100
S&P87
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
S&P97
EV/Sales?0.71CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-35.9%WEAK▾
S&P5
ROA?-32.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-1190225
Enterprise Value?$3.8M
Fundamentals ratios updated end of day